Mike Matson
Stock Analyst at Needham
(3.17)
# 1,186
Out of 4,984 analysts
535
Total ratings
45.23%
Success rate
1.75%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Reiterates: Buy | $121 | $98.50 | +22.84% | 31 | Sep 11, 2025 | |
| LIVN LivaNova | Reiterates: Buy | $64 | $54.53 | +17.37% | 27 | Sep 3, 2025 | |
| NEO NeoGenomics | Maintains: Buy | $8 → $14 | $8.11 | +72.63% | 27 | Aug 29, 2025 | |
| TMDX TransMedics Group | Reiterates: Hold | n/a | $119.81 | - | 12 | Aug 25, 2025 | |
| AORT Artivion | Maintains: Buy | $45 → $50 | $39.95 | +25.16% | 19 | Aug 22, 2025 | |
| IMDX Insight Molecular Diagnostics | Reiterates: Buy | $4.25 | $3.31 | +28.40% | 1 | Aug 18, 2025 | |
| MDT Medtronic | Reiterates: Hold | n/a | $94.58 | - | 21 | Aug 14, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $3 | $1.07 | +180.37% | 21 | Aug 13, 2025 | |
| HAE Haemonetics | Maintains: Buy | $84 → $68 | $49.95 | +36.14% | 14 | Aug 7, 2025 | |
| ENOV Enovis | Maintains: Buy | $57 → $49 | $32.13 | +52.51% | 16 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $448 | $376.88 | +18.87% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $14.93 | - | 20 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $45 | $35.01 | +28.53% | 35 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $108 | $82.70 | +30.59% | 30 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $39.10 | +22.76% | 3 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $61 | $50.48 | +20.84% | 25 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $68.20 | - | 21 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $8.32 | +44.23% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $19.25 | +118.18% | 23 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $41 | $31.83 | +28.81% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $31.91 | - | 21 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $141.23 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $5.73 | +22.16% | 20 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $129.10 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $248.79 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $125.62 | - | 9 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $256.29 | - | 10 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $99.92 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $271.71 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $14.71 | +185.52% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $56.22 | +33.40% | 1 | Feb 18, 2021 |
Boston Scientific
Sep 11, 2025
Reiterates: Buy
Price Target: $121
Current: $98.50
Upside: +22.84%
LivaNova
Sep 3, 2025
Reiterates: Buy
Price Target: $64
Current: $54.53
Upside: +17.37%
NeoGenomics
Aug 29, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $8.11
Upside: +72.63%
TransMedics Group
Aug 25, 2025
Reiterates: Hold
Price Target: n/a
Current: $119.81
Upside: -
Artivion
Aug 22, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $39.95
Upside: +25.16%
Insight Molecular Diagnostics
Aug 18, 2025
Reiterates: Buy
Price Target: $4.25
Current: $3.31
Upside: +28.40%
Medtronic
Aug 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $94.58
Upside: -
Lucid Diagnostics
Aug 13, 2025
Reiterates: Buy
Price Target: $3
Current: $1.07
Upside: +180.37%
Haemonetics
Aug 7, 2025
Maintains: Buy
Price Target: $84 → $68
Current: $49.95
Upside: +36.14%
Enovis
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $49
Current: $32.13
Upside: +52.51%
Aug 1, 2025
Maintains: Buy
Price Target: $442 → $448
Current: $376.88
Upside: +18.87%
Jul 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $14.93
Upside: -
Jul 30, 2025
Maintains: Buy
Price Target: $44 → $45
Current: $35.01
Upside: +28.53%
Jul 18, 2025
Reiterates: Buy
Price Target: $108
Current: $82.70
Upside: +30.59%
Jun 13, 2025
Reiterates: Buy
Price Target: $48
Current: $39.10
Upside: +22.76%
Jun 12, 2025
Downgrades: Hold
Price Target: $61
Current: $50.48
Upside: +20.84%
May 28, 2025
Reiterates: Hold
Price Target: n/a
Current: $68.20
Upside: -
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $8.32
Upside: +44.23%
May 8, 2025
Reiterates: Buy
Price Target: $42
Current: $19.25
Upside: +118.18%
May 8, 2025
Maintains: Buy
Price Target: $51 → $41
Current: $31.83
Upside: +28.81%
Apr 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $31.91
Upside: -
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $141.23
Upside: -
Apr 10, 2025
Reiterates: Buy
Price Target: $7
Current: $5.73
Upside: +22.16%
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $129.10
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $248.79
Upside: -
Mar 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $125.62
Upside: -
Feb 19, 2025
Reiterates: Hold
Price Target: n/a
Current: $256.29
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $99.92
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $271.71
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $14.71
Upside: +185.52%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $56.22
Upside: +33.40%